{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/65736d39d32e730012c98919/65982e1f015a6300176da987?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Novartis and Voyager, JPM Ahead, Epigenetic Engineering; Alex Aravanis","description":"<p>Episode 3 (January 5, 2024): Interview with Co-founder and CEO of Moonwalk Biosciences and former CTO of Illumina, Alex Aravanis; Neuro gene therapy with Novartis and Voyager; GEN reporters look forward to the 2024 J.P. Morgan Healthcare Conference </p><p><br></p><p>Listed below are key references to the <em>GEN</em> stories, media and other items discussed in this episode of <em>Touching Base</em>:</p><p><br></p><ul><li><a href=\"https://www.genengnews.com/topics/drug-discovery/novartis-voyager-ink-up-to-1-3b-expansion-of-neuro-gene-therapy-collaboration/\" rel=\"noopener noreferrer\" target=\"_blank\">Novartis, Voyager Ink Up-to-$1.3B Expansion of Neuro Gene Therapy Collaboration</a></li></ul><p>By Alex Philippidis, GEN, January 2, 2024.</p><p><br></p><ul><li><a href=\"https://www.genengnews.com/topics/genome-editing/moonwalk-biosciences-raises-57m-to-edit-the-epigenome/\" rel=\"noopener noreferrer\" target=\"_blank\">Moonwalk Biosciences Raises $57M to Edit the Epigenome</a></li></ul><p>By Uduak Thomas, GEN, January 4, 2024.</p>","author_name":"Genetic Engineering & Biotechnology News (GEN)"}